1. Home
  2. JNVR vs MTEM Comparison

JNVR vs MTEM Comparison

Compare JNVR & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JNVR
  • MTEM
  • Stock Information
  • Founded
  • JNVR 2018
  • MTEM N/A
  • Country
  • JNVR United States
  • MTEM United States
  • Employees
  • JNVR N/A
  • MTEM N/A
  • Industry
  • JNVR Finance: Consumer Services
  • MTEM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JNVR Finance
  • MTEM Health Care
  • Exchange
  • JNVR Nasdaq
  • MTEM Nasdaq
  • Market Cap
  • JNVR 8.9M
  • MTEM 8.5M
  • IPO Year
  • JNVR 2023
  • MTEM N/A
  • Fundamental
  • Price
  • JNVR $0.74
  • MTEM $1.40
  • Analyst Decision
  • JNVR
  • MTEM
  • Analyst Count
  • JNVR 0
  • MTEM 0
  • Target Price
  • JNVR N/A
  • MTEM N/A
  • AVG Volume (30 Days)
  • JNVR 1.0M
  • MTEM 19.6K
  • Earning Date
  • JNVR 07-30-2024
  • MTEM 08-08-2024
  • Dividend Yield
  • JNVR N/A
  • MTEM N/A
  • EPS Growth
  • JNVR N/A
  • MTEM N/A
  • EPS
  • JNVR N/A
  • MTEM N/A
  • Revenue
  • JNVR $1,947,052.00
  • MTEM $31,763,000.00
  • Revenue This Year
  • JNVR N/A
  • MTEM N/A
  • Revenue Next Year
  • JNVR N/A
  • MTEM N/A
  • P/E Ratio
  • JNVR N/A
  • MTEM N/A
  • Revenue Growth
  • JNVR N/A
  • MTEM N/A
  • 52 Week Low
  • JNVR $0.70
  • MTEM $1.01
  • 52 Week High
  • JNVR $5.50
  • MTEM $9.45
  • Technical
  • Relative Strength Index (RSI)
  • JNVR 42.93
  • MTEM 54.28
  • Support Level
  • JNVR $0.72
  • MTEM $1.26
  • Resistance Level
  • JNVR $0.79
  • MTEM $1.50
  • Average True Range (ATR)
  • JNVR 0.09
  • MTEM 0.10
  • MACD
  • JNVR 0.00
  • MTEM 0.01
  • Stochastic Oscillator
  • JNVR 14.70
  • MTEM 62.16

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

About MTEM Molecular Templates Inc.

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Share on Social Networks: